EMErmia Mousavi Mohammadi

Ermia Mousavi Mohammadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ermia Mousavi Mohammadi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of Topical Tranexamic Acid in Acute Spontaneous Epistaxis: A Randomized Controlled Trial

    by Mohammad Reza Majidi, Imaneh Roshanzamir, Ermia Mousavi Mohammadi

    Objective: Persistent epistaxis and early rebleeding remain clinical challenges despite the self‐limiting nature of many cases. Identification of a simple, noninvasive strategy for hemostasis and recurrence prevention remains a clinical priority. Topical tranexamic acid (TXA) is a potential hemostatic agent, but evidence regarding its effectiveness, particularly for rebleeding, is limited and inconsistent. This study evaluated the role of topical TXA in controlling bleeding and preventing rebleeding in acute spontaneous epistaxis. Methods: In this randomized, double‐blind, placebo‐controlled trial, patients presenting with acute spontaneous epistaxis unresponsive to initial first‐aid measures were enrolled and randomly assigned to receive topical tranexamic acid (TXA) or placebo. Results: A total of 162 patients were included in the study, including 76 in the TXA group and 86 in the control group. Topical TXA was significantly more effective than placebo in achieving initial hemostasis in the emergency department setting ( p = 0.047). No significant differences were observed in rebleeding within 24 h (risk ratio 0.45 (95% CI, 0.17–1.24; p = 0.119)), or in significant rebleeding within 24 h (risk ratio: 1.50 (95% CI, 0.26–8.70; p = 0.651)). Conclusion: In spontaneous epistaxis, the direct application of topical tranexamic acid to the bleeding site is a useful adjunct for achieving hemostasis. This targeted approach may allow effective bleeding control with a smaller amount of the drug, potentially reducing the risk of adverse effects associated with higher doses. Level of Evidence: 1

  • Open Access

    Unusual Presentation of a Rare Disease: A Case Report of Fungal Necrotizing Otitis Media and Mastoiditis

    by Ermia Mousavi Mohammadi, Mohsen Rajati, Hossein Zarrinfar

    Acute necrotizing otitis media is a severe middle ear infection which causes necrosis of the tympanic cavity. A 54‐year‐old female was presented who suffered from diabetes mellitus and end‐stage renal disease presenting with severe otalgia, initially thought to be necrotizing otitis externa. She rapidly progressed to total necrosis of the tympanic membrane. Further assessments confirmed a fungal disease caused by Candida tropicalis and Aspergillus flavus. Immediate antifungal therapy with amphotericin B and subsequent radical mastoidectomy managed to control the disease with no sign of necrosis after 3 months. Early diagnosis, aggressive systemic antifungal treatment, and surgical debridement are vital components for successful management of such cases.


  • Open Access

    Unusual Presentation of a Rare Disease: A Case Report of Fungal Necrotizing Otitis Media and Mastoiditis

    by Ermia Mousavi, Mohsen Rajati, Hossein Zarrinfar

    Acute necrotizing otitis media (ANOM) is a severe middle ear infection which causes necrosis of the tympanic cavity. A 54-year-old female was presented who suffered from diabetes mellitus and end-stage renal disease presenting with severe otalgia, initially thought to be necrotizing otitis externa (NOE). She rapidly progressed to total necrosis of